These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3976432)

  • 1. Treatment of hyperthyroidism with standard doses of radioiodine aiming at ablation.
    Eriksson E; Eriksson K; Wahlberg P
    Acta Med Scand; 1985; 217(1):55-60. PubMed ID: 3976432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ablative radioiodine therapy for hyperthyroidism: long term follow up study.
    Kendall-Taylor P; Keir MJ; Ross WM
    Br Med J (Clin Res Ed); 1984 Aug; 289(6441):361-3. PubMed ID: 6432100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while?
    Jarløv AE; Hegedüs L; Kristensen LO; Nygaard B; Hansen JM
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):325-9. PubMed ID: 7586602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of two fixed doses of 185 and 370 MBq 131I, for the treatment of Graves' disease resistant to antithyroid drugs.
    Esfahani AF; Kakhki VR; Fallahi B; Eftekhari M; Beiki D; Saghari M; Takavar A
    Hell J Nucl Med; 2005; 8(3):158-61. PubMed ID: 16390021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid function and mortality in patients treated for hyperthyroidism.
    Franklyn JA; Sheppard MC; Maisonneuve P
    JAMA; 2005 Jul; 294(1):71-80. PubMed ID: 15998893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC; Zanin DE; Zweers EJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dosing algorithm for individualized radioiodine treatment of cats with hyperthyroidism.
    Peterson ME; Rishniw M
    J Vet Intern Med; 2021 Sep; 35(5):2140-2151. PubMed ID: 34351027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of a novel variable dosing protocol for radioiodine treatment of feline hyperthyroidism.
    Morré WA; Panciera DL; Daniel GB; Monroe WE; Werre S
    J Vet Intern Med; 2018 Nov; 32(6):1856-1863. PubMed ID: 30328158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fixed dose (555 MBq; 15 mCi) radioiodine for the treatment of hyperthyroidism: outcome and its predictors.
    Gupta SK; McGrath S; Rogers K; Attia J; Lewis G; Viswanathan S; Saul M; Allen L
    Intern Med J; 2010 Dec; 40(12):854-7. PubMed ID: 21199224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usage of a fixed dose of radioactive iodine for the treatment of hyperthyroidism: one-year outcome in a regional hospital in Hong Kong.
    Yau JS; Chu KS; Li JK; Chan KW; Lau IT; Yum SW; Chan CW; Mo LK; Kwan WK
    Hong Kong Med J; 2009 Aug; 15(4):267-73. PubMed ID: 19652233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very low doses of radio-iodine for hyperthyroidism. Failure to prevent a high incidence of early hypothyroidism.
    Kalk WJ; Durbach D; Kantor S; Levin J
    S Afr Med J; 1980 Mar; 57(13):479-82. PubMed ID: 7368008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intentional radioiodine ablation in Graves' disease.
    Wise PH; Burnet RB; Ahmad A; Harding PE
    Lancet; 1975 Dec; 2(7947):1231-3. PubMed ID: 53722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioiodine treatment of multinodular non-toxic goitre.
    Nygaard B; Hegedüs L; Gervil M; Hjalgrim H; Søe-Jensen P; Hansen JM
    BMJ; 1993 Oct; 307(6908):828-32. PubMed ID: 8401123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striving for euthyroidism in radioiodine therapy of Graves' disease: a 12-year prospective, randomized, open-label blinded end point study.
    Chen DY; Schneider PF; Zhang XS; He ZM; Jing J; Chen TH
    Thyroid; 2011 Jun; 21(6):647-54. PubMed ID: 21563916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioiodine (I-131) therapy and the incidence of hypothyroidism.
    Tavintharan S; Sundram FX; Chew LS
    Ann Acad Med Singap; 1997 Jan; 26(1):128-31. PubMed ID: 9140591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.
    Allahabadia A; Daykin J; Sheppard MC; Gough SC; Franklyn JA
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3611-7. PubMed ID: 11502786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radioiodine 131I therapy of hyperthyroidism on an outpatient basis - safe, effective and economic option].
    Jiskra J; Kubinyi J; Telička Z
    Vnitr Lek; 2012 Feb; 58(2):94-8. PubMed ID: 22463087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.